semaglutide vision linked to higher risk of problems, FDA data analysis shows Rare risk of vision loss

When the medication is injected subcutaneously into the fatty tissue beneath the skin, it triggers a localized inflammatory response as part of the body's normal immune surveillance

Strength training is one of the most powerful tools you have to support your hormones naturally and boost GLP-1 productionno needles required

8

SELECT (NEJM 2023, PMID 37952131): 20% MACE reduction in non-diabetic adults with overweight/obesity + CVD

Retatrutide is producing larger losses, faster

21 For example, in dietinduced obese mice, use of a novel GIP analogue enhanced GLP-1RA-induced body weight loss and improved glycemic control secondary to suppression of food intake